BlackRock Japan’s Harvard Bioscience HBIO Stock Holding History

BlackRock Japan’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-56	Closed	-$2K	–	1447
2015 Q4	$2K	Buy	+56	New	+$1.92K	﹤0.01%	1369
2015 Q2	–	Sell	-957	Closed	-$56K	–	1366
2015 Q1	$56K	Hold	957	–	–	﹤0.01%	1039
2014 Q4	$54K	Buy	+957	New	+$45.6K	﹤0.01%	1085
2014 Q2	–	Sell	-995	Closed	-$47K	–	1332
2014 Q1	$47K	Sell	995 -1,769	-64%	-$80.5K	﹤0.01%	1171
2013 Q4	$130K	Sell	2,764 -1,266	-31%	-$55.3K	﹤0.01%	980
2013 Q3	$161K	Hold	4,030	–	–	﹤0.01%	938
2013 Q2	$144K	Buy	+4,030	New	+$154K	﹤0.01%	922

Other funds holding HBIO

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Japan's HBIO Position: Q1 2016 in Review

BlackRock Japan sold out of Harvard Bioscience (HBIO) in Q1 2016, closing a stake of 56 shares — an estimated $2K sold.

BlackRock Japan first reported a position in HBIO in Q2 2013 and held it in 7 quarters. The position peaked at $161K in Q3 2013. 81 funds tracked by Wall St. Rank hold HBIO as of Q1 2016.

BlackRock Japan reported no remaining Harvard Bioscience position as of Q1 2016 after selling out during the quarter.
BlackRock Japan sold 56 Harvard Bioscience shares in Q1 2016, an estimated $2K.
BlackRock Japan first reported a position in Harvard Bioscience in Q2 2013 and held it in 7 quarters.
BlackRock Japan's Harvard Bioscience position peaked at $161K in Q3 2013.
81 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2016.

Based on BlackRock Japan's 13F filing for Q1 2016, filed 10 May 2016.